de Morgan Stanley Ironwood Pharmaceuticals IRWD Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 7.83 M | Comprar |
1,859,914
+1,035,095
| +125% | +USD 3.99 M | ﹤0.01% | 3897 |
|
|
2026
Q1 | USD 2.9 M | Comprar |
824,819
+85,134
| +12% | +USD 349 k | ﹤0.01% | 4494 |
|
|
2025
Q4 | USD 2.49 M | Comprar |
739,685
+262,585
| +55% | +USD 682 k | ﹤0.01% | 4657 |
|
|
2025
Q3 | USD 625 k | Vender |
477,100
-16,934
| -3% | -USD 17.5 k | ﹤0.01% | 5413 |
|
|
2025
Q2 | USD 354 k | Vender |
494,034
-1,369,187
| -73% | -USD 1.07 M | ﹤0.01% | 5622 |
|
|
2025
Q1 | USD 2.74 M | Vender |
1,863,221
-2,161,472
| -54% | -USD 5.15 M | ﹤0.01% | 4410 |
|
|
2024
Q4 | USD 17.8 M | Vender |
4,024,693
-296,896
| -7% | -USD 1.2 M | ﹤0.01% | 2869 |
|
|
2024
Q3 | USD 17.8 M | Vender |
4,321,589
-539,239
| -11% | -USD 2.9 M | ﹤0.01% | 2908 |
|
|
2024
Q2 | USD 31.7 M | Comprar |
4,860,828
+2,182,712
| +82% | +USD 15.4 M | ﹤0.01% | 2177 |
|
|
2024
Q1 | USD 23.3 M | Comprar |
2,678,116
+530,298
| +25% | +USD 6.43 M | ﹤0.01% | 2529 |
|
|
2023
Q4 | USD 24.6 M | Comprar |
2,147,818
+247,035
| +13% | +USD 2.44 M | ﹤0.01% | 2476 |
|
|
2023
Q3 | USD 18.3 M | Vender |
1,900,783
-1,167,556
| -38% | -USD 11.4 M | ﹤0.01% | 2544 |
|
|
2023
Q2 | USD 32.6 M | Vender |
3,068,339
-730,654
| -19% | -USD 7.85 M | ﹤0.01% | 1976 |
|
|
2023
Q1 | USD 40 M | Comprar |
3,798,993
+1,140,486
| +43% | +USD 12.8 M | ﹤0.01% | 1754 |
|
|
2022
Q4 | USD 32.9 M | Comprar |
2,658,507
+455,105
| +21% | +USD 5.16 M | ﹤0.01% | 1875 |
|
|
2022
Q3 | USD 22.8 M | Vender |
2,203,402
-374,129
| -15% | -USD 4.24 M | ﹤0.01% | 2052 |
|
|
2022
Q2 | USD 29.7 M | Comprar |
2,577,531
+293,707
| +13% | +USD 3.46 M | ﹤0.01% | 1858 |
|
|
2022
Q1 | USD 28.7 M | Comprar |
2,283,824
+1,230,402
| +117% | +USD 14.1 M | ﹤0.01% | 1746 |
|
|
2021
Q4 | USD 12.3 M | Vender |
1,053,422
-654,367
| -38% | -USD 8.03 M | ﹤0.01% | 2709 |
|
|
2021
Q3 | USD 22.3 M | Comprar |
1,707,789
+253,636
| +17% | +USD 3.28 M | ﹤0.01% | 1978 |
|
|
2021
Q2 | USD 18.7 M | Comprar |
1,454,153
+449,360
| +45% | +USD 5.14 M | ﹤0.01% | 2231 |
|
|
2021
Q1 | USD 11.2 M | Vender |
1,004,793
-263,728
| -21% | -USD 2.79 M | ﹤0.01% | 2527 |
|
|
2020
Q4 | USD 14.4 M | Comprar |
1,268,521
+373,810
| +42% | +USD 4.09 M | ﹤0.01% | 2128 |
|
|
2020
Q3 | USD 8.05 M | Comprar |
894,711
+770,078
| +618% | +USD 7.65 M | ﹤0.01% | 2229 |
|
|
2020
Q2 | USD 1.29 M | Comprar |
124,633
+74,294
| +148% | +USD 760 k | ﹤0.01% | 3975 |
|
|
2020
Q1 | USD 508 k | Vender |
50,339
-252,721
| -83% | -USD 2.97 M | ﹤0.01% | 4356 |
|
|
2019
Q4 | USD 4.03 M | Comprar |
303,060
+181,465
| +149% | +USD 2 M | ﹤0.01% | 3432 |
|
|
2019
Q3 | USD 1.04 M | Comprar |
121,595
+31,302
| +35% | +USD 304 k | ﹤0.01% | 4275 |
|
|
2019
Q2 | USD 988 k | Vender |
90,293
-380,542
| -81% | -USD 4.26 M | ﹤0.01% | 4230 |
|
|
2019
Q1 | USD 5.34 M | Vender |
470,835
-409,296
| -47% | -USD 4.57 M | ﹤0.01% | 2640 |
|
|
2018
Q4 | USD 7.64 M | Comprar |
880,131
+572,547
| +186% | +USD 6.57 M | ﹤0.01% | 2411 |
|
|
2018
Q3 | USD 4.76 M | Vender |
307,584
-123,493
| -29% | -USD 1.95 M | ﹤0.01% | 3236 |
|
|
2018
Q2 | USD 6.9 M | Comprar |
431,077
+28,287
| +7% | +USD 419 k | ﹤0.01% | 2782 |
|
|
2018
Q1 | USD 5.2 M | Comprar |
402,790
+28,119
| +8% | +USD 350 k | ﹤0.01% | 2989 |
|
|
2017
Q4 | USD 4.7 M | Comprar |
374,671
+88,940
| +31% | +USD 1.16 M | ﹤0.01% | 3173 |
|
|
2017
Q3 | USD 3.77 M | Comprar |
285,731
+69,686
| +32% | +USD 959 k | ﹤0.01% | 3271 |
|
|
2017
Q2 | USD 3.42 M | Vender |
216,045
-43,325
| -17% | -USD 630 k | ﹤0.01% | 3289 |
|
|
2017
Q1 | USD 3.71 M | Vender |
259,370
-313,010
| -55% | -USD 4.28 M | ﹤0.01% | 3192 |
|
|
2016
Q4 | USD 7.33 M | Comprar |
572,380
+387,724
| +210% | +USD 4.9 M | ﹤0.01% | 2594 |
|
|
2016
Q3 | USD 2.46 M | Vender |
184,656
-20,230
| -10% | -USD 236 k | ﹤0.01% | 3319 |
|
|
2016
Q2 | USD 2.24 M | Vender |
204,886
-373,269
| -65% | -USD 3.65 M | ﹤0.01% | 3332 |
|
|
2016
Q1 | USD 5.3 M | Vender |
578,155
-572,648
| -50% | -USD 4.72 M | ﹤0.01% | 2471 |
|
|
2015
Q4 | USD 11.2 M | Vender |
1,150,803
-59,345
| -5% | -USD 574 k | ﹤0.01% | 1882 |
|
|
2015
Q3 | USD 10.6 M | Vender |
1,210,148
-6,328,354
| -84% | -USD 59 M | ﹤0.01% | 1901 |
|
|
2015
Q2 | USD 76.1 M | Vender |
7,538,502
-1,033,748
| -12% | -USD 12 M | 0.03% | 636 |
|
|
2015
Q1 | USD 115 M | Vender |
8,572,250
-653,503
| -7% | -USD 8.57 M | 0.04% | 456 |
|
|
2014
Q4 | USD 118 M | Vender |
9,225,753
-391,042
| -4% | -USD 4.48 M | 0.04% | 453 |
|
|
2014
Q3 | USD 104 M | Vender |
9,616,795
-35,644
| -0.4% | -USD 408 k | 0.04% | 500 |
|
|
2014
Q2 | USD 124 M | Vender |
9,652,439
-53,605
| -0.6% | -USD 583 k | 0.05% | 432 |
|
|
2014
Q1 | USD 100 M | Vender |
9,706,044
-298,440
| -3% | -USD 3.36 M | 0.04% | 475 |
|
|
2013
Q4 | USD 97.3 M | Vender |
10,004,484
-1,377,327
| -12% | -USD 12.4 M | 0.04% | 465 |
|
|
2013
Q3 | USD 113 M | Vender |
11,381,811
-224,119
| -2% | -USD 2.2 M | 0.05% | 378 |
|
|
2013
Q2 | USD 96.5 M | Comprar |
+11,605,930
| Nuevas | +USD 141 M | 0.05% | 417 |
|
Otros fondos que tienen IRWD en su cartera
SCM
Posición de Morgan Stanley en IRWD: resumen de T2 2026
Morgan Stanley aumentó su participación en Ironwood Pharmaceuticals (IRWD) en 125% durante T2 2026, al comprar aproximadamente USD 3.99 M y elevar la posición a 1,859,914 acciones con un valor de USD 7.83 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #3897.
Morgan Stanley reportó por primera vez una posición en IRWD en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 124 M en T2 2014. Al cierre de T2 2026, 212 fondos que sigue Wall St. Rank mantienen una posición en IRWD.
- Al cierre de T2 2026, Morgan Stanley tenía 1,859,914 acciones de Ironwood Pharmaceuticals con un valor de USD 7.83 M.
- Morgan Stanley compró 1,035,095 acciones de Ironwood Pharmaceuticals en T2 2026, por un monto estimado de USD 3.99 M.
- Ironwood Pharmaceuticals representó ﹤0.01% de la cartera de Morgan Stanley en T2 2026 y fue su posición número 3897.
- Morgan Stanley reportó por primera vez una posición en Ironwood Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Morgan Stanley en Ironwood Pharmaceuticals alcanzó su máximo de USD 124 M en T2 2014.
- Al cierre de T2 2026, 212 fondos que sigue Wall St. Rank tenían Ironwood Pharmaceuticals en cartera.
Según el Informe 13F de Morgan Stanley correspondiente a T2 2026, presentado el 13 ago 2026.